User profiles for Jean-Luc Balligand

Balligand Jean-Luc

Université catholique de Louvain
Verified email at uclouvain.be
Cited by 24384

[HTML][HTML] A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy

…, M Luchtefeld, V Poli, MD Schneider, JL Balligand… - Cell, 2007 - cell.com
Postpartum cardiomyopathy (PPCM) is a disease of unknown etiology and exposes women
to high risk of mortality after delivery. Here, we show that female mice with a cardiomyocyte-…

Nitric oxide and cardiac function

RA Kelly, JL Balligand, TW Smith - Circulation research, 1996 - Am Heart Assoc
Over the past 5 years there has been an explosion of new information on the physiological
and pathophysiological roles of NO within the heart as in other organ systems. In this review, …

Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

JL Balligand, RA Kelly, PA Marsden… - Proceedings of the …, 1993 - National Acad Sciences
Nitric oxide (NO) synthesized from L-arginine is a ubiquitous intracellular chemical messenger
and is involved in signal transduction in diverse mammalian cells, including vascular …

The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

…, N Khandoudi, A Bril, JL Balligand… - The Journal of …, 1998 - Am Soc Clin Investig
Beta1- and beta2-adrenoceptors in heart muscle cells mediate the catecholamine-induced
increase in the force and frequency of cardiac contraction. Recently, in addition, we …

Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

…, E De Azambuja, JL Balligand… - European journal of …, 2011 - Wiley Online Library
The reductions in mortality and morbidity being achieved among cancer patients with current
therapies represent a major achievement. However, given their mechanisms of action, …

Nitric oxide signalling in cardiovascular health and disease

C Farah, LYM Michel, JL Balligand - Nature Reviews Cardiology, 2018 - nature.com
Nitric oxide (NO) signalling has pleiotropic roles in biology and a crucial function in cardiovascular
homeostasis. Tremendous knowledge has been accumulated on the mechanisms of …

[HTML][HTML] Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase

…, S Moniotte, JP Desager, JL Balligand - The Journal of …, 1999 - Am Soc Clin Investig
Hypercholesterolemia is a central pathogenic factor of endothelial dysfunction caused in
part by an impairment of endothelial nitric oxide (NO) production through mechanisms that …

Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in …

JL Balligand, D Ungureanu-Longrois… - Journal of Biological …, 1994 - Elsevier
Cellular constituents of heart muscle contain both constitutive and inducible nitric oxide (NO)
signaling pathways that modulate the contractile properties of cardiac myocytes. The …

Upregulation of β3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium

…, O Feron, JN Trochu, C Gauthier, JL Balligand - Circulation, 2001 - Am Heart Assoc
Background—Contrary to β 1 - and β 2 -adrenoceptors, β 3 -adrenoceptors mediate a negative
inotropic effect in human ventricular muscle. To assess their functional role in heart failure…

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the …

…, SD Anker, P Aukrust, JL Balligand… - European journal of …, 2009 - Wiley Online Library
The increasing prevalence of heart failure poses enormous challenges for health care systems
worldwide. Despite effective medical interventions that target neurohumoral activation, …